Tinberg et al., 2013 - Google Patents
Computational design of ligand-binding proteins with high affinity and selectivityTinberg et al., 2013
View HTML- Document ID
- 3212801219026024860
- Author
- Tinberg C
- Khare S
- Dou J
- Doyle L
- Nelson J
- Schena A
- Jankowski W
- Kalodimos C
- Johnsson K
- Stoddard B
- Baker D
- Publication year
- Publication venue
- Nature
External Links
Snippet
The ability to design proteins with high affinity and selectivity for any given small molecule is a rigorous test of our understanding of the physiochemical principles that govern molecular recognition. Attempts to rationally design ligand-binding proteins have met with little …
- 230000027455 binding 0 title abstract description 114
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/16—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for molecular structure, e.g. structure alignment, structural or functional relations, protein folding, domain topologies, drug targeting using structure data, involving two-dimensional or three-dimensional structures
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/28—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for programming tools or database systems, e.g. ontologies, heterogeneous data integration, data warehousing or computing architectures
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tinberg et al. | Computational design of ligand-binding proteins with high affinity and selectivity | |
Bennett et al. | Improving de novo protein binder design with deep learning | |
Hie et al. | Efficient evolution of human antibodies from general protein language models | |
Chen et al. | A cell-free nanobody engineering platform rapidly generates SARS-CoV-2 neutralizing nanobodies | |
Huang et al. | Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4 | |
Wilkens et al. | Solution structure of the ε subunit of the F1-ATPase from Escherichia coli and interactions of this subunit with β subunits in the complex | |
McShan et al. | TAPBPR promotes antigen loading on MHC-I molecules using a peptide trap | |
Zhu et al. | Protein interaction discovery using parallel analysis of translated ORFs (PLATO) | |
Hsu et al. | Entropy calculation of HIV-1 Env gp120, its receptor CD4, and their complex: an analysis of configurational entropy changes upon complexation | |
Xu et al. | Internally deleted human tRNA synthetase suggests evolutionary pressure for repurposing | |
Gray et al. | Unravelling the molecular basis of high affinity nanobodies against HIV p24: in vitro functional, structural, and in silico insights | |
Wilkinson et al. | High Resolution NMR-based Model for the Structure of a scFv-IL-1β Complex | |
Harris et al. | An engineered switch in T cell receptor specificity leads to an unusual but functional binding geometry | |
Jha et al. | An improved Protein G with higher affinity for human/rabbit IgG Fc domains exploiting a computationally designed polar network | |
Madan et al. | Mutational fitness landscapes reveal genetic and structural improvement pathways for a vaccine-elicited HIV-1 broadly neutralizing antibody | |
Heyne et al. | Generating quantitative binding landscapes through fractional binding selections combined with deep sequencing and data normalization | |
Vlach et al. | D-retrovirus morphogenetic switch driven by the targeting signal accessibility to Tctex-1 of dynein | |
Tit-Oon et al. | Prediction of the binding interface between monoclonal antibody m102. 4 and Nipah attachment glycoprotein using structure-guided alanine scanning and computational docking | |
Bijak et al. | The current role and evolution of X-ray crystallography in drug discovery and development | |
Rusnati et al. | Recent strategic advances in CFTR drug discovery: an overview | |
Krueger et al. | Atomistic ensemble modeling and small-angle neutron scattering of intrinsically disordered protein complexes: applied to minichromosome maintenance protein | |
Schlimgen et al. | Structural basis for selectivity and antagonism in extracellular GPCR-nanobodies | |
van Ingen et al. | Extension of the binding motif of the Sin3 interacting domain of the Mad family proteins | |
Hardebeck et al. | A FRET-based assay for the identification of PCNA inhibitors | |
Tam et al. | Targeting Ras-binding domain of ELMO1 by computational nanobody design |